Charles + Colvard Ltd. buy krebskrebs
Start price
03.05.22
/
50%
€1.29
Target price
03.05.23
€1.80
Performance (%)
-33.33%
End price
04.05.23
€0.86
Summary
This prediction ended on 04.05.23 with a price of €0.86. Massive losses of -33.33% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Charles + Colvard Ltd. | -10.811% | -10.811% | -76.145% |
iShares Core DAX® | -0.051% | 4.829% | 17.062% |
iShares Nasdaq 100 | 1.659% | 2.417% | 38.705% |
iShares Nikkei 225® | 0.658% | -2.173% | 13.159% |
iShares S&P 500 | 0.964% | 2.547% | 30.492% |
Comments by krebskrebs for this prediction
In the thread Charles + Colvard Ltd. diskutieren
Buy mit Kursziel 1,8
In the thread Trading Charles + Colvard Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten